USPTO serial 79291195
ZYEPTI
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 3, 2021
- Examiner
- KOVALSKY, LAURA G
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ZYEPTI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*
Plus Government fees of $325
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Lundbeck Seattle BioPharmaceuticals Inc.
US
Other trademarks owned by Lundbeck Seattle BioPharmaceuticals Inc.
Lundbeck Seattle BioPharmaceuticals Inc.
US
Other trademarks owned by Lundbeck Seattle BioPharmaceuticals Inc.
Lundbeck Seattle BioPharmaceuticals Inc.
US
Other trademarks owned by Lundbeck Seattle BioPharmaceuticals Inc.
US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Maren C. Perry
Maren C. Perry King & Spalding LLP1185 Avenue of the AmericasNew York, NY 10036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and medical preparations and substances for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions; Vaccines; Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; Pharmaceutical preparations and substances acting on the central nervous system; Central nervous system stimulants; Pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological disorders and diseases; Pharmaceutical preparations and substances for the prevention and treatment of dementia, Alzheimer's disease and disorder, dizziness, seizures, stroke, depression, cognitive impairment, cognitive disorders and diseases, mood disorders, psychosis, anxiety, apathy, epilepsy, Lennox-Gastaut syndrome (LGS), sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson's disease and disorder, falls, movement disorders and diseases, tremor, schizophrenia, bipolar disorder and disease, mania, ADHD, PTSD, agitation, aggression, autism, melancholy, OCD, Tourette's syndrome, PSP, restlessness, akathisia, fatigue, somnolence, nausea, cancer, migraine, headaches, pain, alcoholism and dependency; Preparations, substances, reagents and agents for diagnostic and medical purposes, namely, for use in the prevention, management and treatment of headaches, migraines, pain, and neurological disorders and conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Lundbeck Seattle BioPharmaceuticals Inc.
- Other trademarks owned by Lundbeck Seattle BioPharmaceuticals Inc.
- Other trademarks owned by Lundbeck Seattle BioPharmaceuticals Inc.
- Other trademarks owned by H. Lundbeck A/S
- Other trademarks in Class 005
- Similar marks named ZYEPTI
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 3, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 20, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 7, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 7, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 3, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 3, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 18, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 18, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 17, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Apr 28, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 28, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 28, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 12, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 25, 2021 | ALIE | ASSIGNED TO LIE | — |
| Mar 24, 2021 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Mar 15, 2021 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Mar 15, 2021 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Mar 15, 2021 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 26, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 26, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2021 | ALIE | ASSIGNED TO LIE | — |
| Nov 25, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 9, 2020 | DCPN | CHANGE OF OWNER RECEIVED FROM IB | — |
| Oct 11, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 23, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 23, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 18, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 18, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 17, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 14, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 14, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 13, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 6, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |